Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
JOURNAL CLUB 2010 - Gastroenterology
Optimizing Adherence and Potential Outcomes in Inflammatory Bowel Disease
February - 2010
Editorial overview John Marshall, MD, MSc, FRCPC, AGAF, Head, Clinical Research for the Division of Gastroenterology Member, Farncombe Family Digestive Health Research Institute Associate Professor of Medicine, McMaster University,...
PRIORITY PRESS - Canadian Digestive Diseases Week
Optimizing Adherence and Potential Outcomes in IBD
Toronto, Ontario / February 27- March 2, 2010
Toronto - Ulcerative colitis (UC) and Crohn’s disease are chronic conditions demanding lifelong care. In mild to moderate UC disease, 5-ASA formulations such as mesalamine are the mainstay of first-line therapy. In order to reduce the...
PRIORITY PRESS - 5th Congress of the European Crohn’s and Colitis Organisation (ECCO)
Optimizing 5-ASA Therapy in the Management of Ulcerative Colitis
Prague, Czech Republic / February 25-27, 2010
Prague - For several decades, 5-aminosalicylic acid (5-ASA) compounds have been used to treat patients with ulcerative colitis (UC), both during flares and as maintenance therapy. With proven efficacy and a well-established safety profile,...
PHYSICIAN PERSPECTIVE - Viewpoint based on the following article: Gastroenterol Hepatol 2009;5(7):494-500
The Role of Long-term 5-ASA Maintenance in Preventing Relapse of Ulcerative Colitis
November 2009
INTRODUCTION There are a number of advantages for controlling ulcerative colitis (UC) with 5-aminosalicylic acid (5-ASA) preparations relative to immunomodulators or biologics, including a low relative risk of adverse effects, the...
FRONTLINE - Based on presentations from the Second Eastern Ontario Gastrointestinal Stromal Tumours (GIST) Consensus Meeting
Second Eastern Ontario Conference on the Management of GIST
Ottawa, Ontario / November 6, 2009
Two years ago, the first eastern Ontario consensus conference on the detection, staging and treatment of gastrointestinal stromal tumours (GISTs) provided a summary of current management in the context of regional resources. A second...
PRIORITY PRESS - 74th Annual Scientific Meeting of the American College of Gastroenterology
Ulcerative Colitis: Focus on Persistence with 5-ASA Therapy
San Diego, California / October 23-28, 2009
San Diego - The ultimate goal of treatment for ulcerative colitis (UC) is mucosal healing. Although 5-aminosalicylic acid (5-ASA) agents have demonstrated efficacy in UC, as many as 60% of patients do not take the medication as prescribed,...
PRIORITY PRESS - 110th Annual Digestive Disease Week
Examining the Role of 5-Aminosalicylates in the Treatment of Crohn’s Disease
Chicago, Illinois / May 30-June 4, 2009
Chicago - Crohn’s disease (CD) is characterized by periods of disease control or remission followed by flare-ups. Most affected patients have an uncomplicated clinical course characterized by remission or mild disease. As top-down therapy...
PRIORITY PRESS - American Transplant Congress 2009
Immunosuppression in Liver Transplant Recipients
Boston, Massachusetts / May 30-June 3, 2009
Boston - Patients with hepatitis C (HCV) who undergo liver transplantation typically experience less favourable patient and graft survival compared with non-HCV liver transplant recipients, primarily because HCV frequently recurs, damaging...
MEDICAL OPTIONS in Gastroenterology
Proton Pump Inhibitor Treatment Optimization
Reviews from published literature - March 2009
Towards Improved Treatment Outcomes: Revisiting GERD Symptomatology Dr. David Armstrong, McMaster University Proton Pump Inhibitors in the Elderly: Special Considerations Dr. Gilbert Doummar. Centre hospitalier Pierre-Boucher Current...